Work

Modern diagnosis of hepatocellular carcinoma: Utilization of liver biopsy and genomic markers

Year: 2009

Type: article

Abstract: The incidence of Hepatocellular Carcinoma (HCC) has been rising in both Europe and the United States, largely due to the growing prevalence of hepatitis C (HCV) cirrhosis [1]. Despite advances in technology and available treatments, there has been little improvement in the overall survival likely due to the fact that most patients are diagnosed at advanced stages [2,3]. Cirrhosis is the most important risk factor for the development of HCC [4]. HCV and hepatitis B (HBV) are the major etiological agents that lead to HCC [5,6], though all etiologies that lead to cirrhosis also increase the risk of developing HCC.

Source: Journal of Hepatology

DOI: 10.1016/j.jhep.2009.01.006

Author: Jorge A. Marrero

Institutions: University of Michigan, A. Alfred Taubman Health Care Center

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $5,500